For the current REF see the REF 2021 website REF 2021 logo

Output details

2 - Public Health, Health Services and Primary Care

University of Birmingham

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation

Type
D - Journal article
Title of journal
Health Technology Assessment
Article number
-
Volume number
15
Issue number
14
First page of article
1
ISSN of journal
1366-5278
Year of publication
2011
URL
-
Number of additional authors
10
Additional information

The author made a substantial contribution to:

the organisation of the conduct of the study

carrying out the study (including acquisition of study data)

AND

The author helped draft the output

The author helped critique the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
B - Health Service Research
Citation count
22
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-